Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.40 |
| ▸ | ACE | P12821 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.35 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20132290 | 0.93 | AKT1 (0.43) | AKT1NOD1ACEP2RY12 | |
| SCHEMBL20873310 | 0.93 | AKT1 (0.43) | AKT1NOD1ACEP2RY12 | |
| SCHEMBL31235846 | 0.88 | AKT1 (0.39) | AKT1ACEPTGS1PTGS2HDAC3 | |
| SCHEMBL18495353 | 0.87 | PTGS1 (0.42) | AKT1PTGS1PTGS2HDAC3HDAC1 | |
| SCHEMBL22044586 | 0.84 | AKT1 (0.48) | AKT1ACEHDAC3HDAC1HDAC8 | |
| SCHEMBL15919172 | 0.84 | AKT1 (0.41) | AKT1ACEKMT2APOLBP2RY12 | |
| SCHEMBL16273727 | 0.84 | AKT1 (0.41) | AKT1ACEKMT2APOLBP2RY12 | |
| SCHEMBL22045035 | 0.83 | AKT1 (0.48) | AKT1ACEPTGS1PTGS2HDAC3 | |
| SCHEMBL16156903 | 0.83 | PTGS1 (0.53) | NOD1PTGS1PTGS2FOLH1 | |
| SCHEMBL24983125 | 0.82 | NOD1 (0.47) | NOD1PTGS1PTGS2KMT2AFOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | disclosed |
| WO-2024239281-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2024-11-28 | — | — | WO | disclosed |